Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
16.82 (USD) • At close November 4, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -245.595 | -221.863 | -169.069 | -139.7 | -77.27 | -74.518 | -29.497 | -42.854 | -67.982 | -9.531 | -7.616 | -6.058 |
| Afschrijvingen & Amortisatie
| 7.098 | 6.266 | 5.373 | 1.145 | 0.426 | 0.33 | 0.2 | 0.169 | 0.045 | 0 | 0 | 0.009 |
| Uitgestelde Inkomstenbelasting
| -10.147 | 0 | 3.148 | 0.999 | -1.066 | -0.484 | 0.654 | 0.225 | 46.36 | 0 | 0 | 0.002 |
| Aandelen Gebaseerde Vergoedingen
| 39.406 | 31.009 | 29.237 | 18.567 | 13.371 | 13.601 | 4.036 | 2.909 | 2.38 | 0.177 | -0.148 | 0.486 |
| Verandering in Werkkapitaal
| 13.458 | 6.076 | -3.386 | 15.029 | -3.726 | 4.385 | -2.027 | 2.123 | 0.669 | -1.474 | 0.736 | -1.588 |
| Vorderingen
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Voorraden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 10.147 | 9.674 | -4.827 | 11.015 | -2.722 | 5.89 | -1.141 | -0.041 | 0.487 | 0.917 | -0.158 | 0.159 |
| Overig Werkkapitaal
| -10.147 | -3.598 | 1.441 | 4.014 | -1.004 | -1.505 | -0.886 | 2.164 | 0.182 | -2.391 | 0.894 | -1.747 |
| Overige Niet-Contante Posten
| 0.864 | 0.37 | 13.534 | 29.32 | 3.602 | 2.898 | 0.522 | 0.162 | 1.112 | 1.085 | 0.573 | 0.213 |
| Kasstroom uit Operationele Activiteiten
| -194.916 | -178.142 | -121.163 | -74.64 | -64.663 | -53.788 | -26.112 | -37.266 | -17.416 | -9.743 | -6.455 | -6.936 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| -16.472 | -8.619 | -7.715 | -29.059 | -23.269 | -1.453 | -0.07 | -0.487 | -0.412 | 0 | 0 | 0 |
| Netto Overnames
| 0.036 | 42.726 | 0.095 | 8.452 | 0.016 | 76.348 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| -390.92 | -376.327 | -245.875 | -209.343 | -184.298 | -141.087 | -27.204 | -122.277 | -33.693 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 309.326 | 272.894 | 272.443 | 141.811 | 168.556 | 61.276 | 102.289 | 56.705 | 2.43 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| -0.036 | -0.104 | -0.095 | -8.452 | -0.016 | -0.356 | 0 | 0 | 0 | 0 | 0 | 0.003 |
| Kasstroom uit Investeringsactiviteiten
| -98.066 | -69.326 | 18.853 | -96.591 | -39.011 | -5.272 | 75.015 | -66.059 | -31.675 | 0 | 0 | 0.003 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| -0.139 | -0.172 | -0.201 | -5.557 | 0 | 0 | 0 | -48.738 | -7.641 | -1.41 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 208.394 | 154.704 | 37.681 | 281.354 | 178.104 | 154.022 | 25.406 | 4.343 | 112.05 | 0 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| 0 | -0.047 | 0 | -0.072 | 0.726 | -0.668 | 0.035 | 0.155 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 0.146 | 0.975 | 0.038 | 12.821 | -1.039 | 0.148 | 0.025 | 0 | 21.106 | 1.978 | 17.876 | 2.5 |
| Kasstroom uit Financieringsactiviteiten
| 208.401 | 155.288 | 0.038 | 282.989 | 177.791 | 153.502 | 0.025 | 0 | 125.515 | 0.568 | 17.876 | 2.5 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -84.581 | -92.18 | -64.629 | 111.758 | 74.117 | 94.442 | 48.922 | -50.244 | 76.424 | -9.175 | 11.421 | -4.433 |
| Kaspositie aan het Einde van de Periode
| 57.276 | 141.857 | 234.037 | 298.666 | 186.908 | 112.791 | 78.72 | 29.798 | 80.042 | 3.618 | 12.793 | 1.372 |